Message from the Director

Greetings

Director, Research Institute for Radiation Biology and Medicine
Satoshi Tashiro

The Research Institute for Radiation Biology and Medicine (RIRBM) at Hiroshima University was founded in 1961 for the medical treatment of atomic bomb survivors and basic research on radiation biology. Since then, the institute has produced world-leading research achievements in medicine and medical science for A-bomb survivors. Now, RIRBM is developing research and education in the field of comprehensive radiation biology and medicine covering from basic radiation biology to radiation emergency medicine.

 When the Fukushima Daiichi nuclear power plant accident occurred in 2011, RIRBM and Hiroshima University Hospital dispatched "Emergency Medicine Assistant Teams" to support radiation emergency medicine in Fukushima. RIRBM has also conducted basic studies including "Low dose radiation effects advanced research program", using the state-of-the-art techniques, such as the next generation sequencer and high-throughput bio-imaging systems, to study the effect of low-dose radiation on human health.

 RIRBM was designated as “Joint Usage / Research Center for Radiation Effects and Medical Science” on FY2010(2010-2015) to contribute to the scientific society associated with radiation medicine and biology. Based on the 6-year research results obtained by this project, “Network-type Joint Usage / Research Center for Radiation Disaster Medical Science” was established in FY2016 (2016-2021) by a coalition of three research institutes; RIRBM, Atomic Bomb Disease Institute at Nagasaki University and Fukushima Global Medical Science Center at Fukushima Medical University. As the central institute of this joint project, RIRBM has strived to build an academic foundation for advanced and integrated radiation disaster and medical science research to offer the research outcomes to the international community as well as to cultivate young investigators. On the other hand, Hiroshima University has been designated as “Advanced Radiation Emergency Medicine Support Center” and “Nuclear Disaster Medical Care/General Support Center” by the Nuclear Regulation Authority. RIRBM also endeavors to contribute to this new nation-wide system for nuclear disaster medicine as the core institute at Hiroshima University.

  We will pursue to bring out the highest standards of research and education in radiation biology and medicine as a world-leading research institution. We would be grateful for your continued support and cooperation.


up